Evidence map›Paper›PMID 26360634›Full record

ArticleThe Journal of organic chemistry2015

Synthesis of Naamidine A and Selective Access to N(2)-Acyl-2-aminoimidazole Analogues.

Joseph B Gibbons, Justin M Salvant, Rachel M Vaden, Ki-Hyeok Kwon, Bryan E Welm, Ryan E Looper

Open access · greenAbstract read
In one paragraph

Article in The Journal of organic chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Total synthesis and cytotoxicity of Leucetta alkaloids.Bioorganic & medicinal chemistry · 2017
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Joseph B GibbonsDepartment of Chemistry, University of Utah , 315 South 1400 East, Salt Lake City, Utah 84112, United States.
Justin M SalvantDepartment of Chemistry, University of Utah , 315 South 1400 East, Salt Lake City, Utah 84112, United States.
Rachel M VadenDepartment of Chemistry, University of Utah , 315 South 1400 East, Salt Lake City, Utah 84112, United States.
Ki-Hyeok KwonDepartment of Chemistry, University of Utah , 315 South 1400 East, Salt Lake City, Utah 84112, United States.
Bryan E WelmImmunobiology and Cancer Program, Oklahoma Medical Research Foundation , 825 Northeast 13th Street, Oklahoma City, Oklahoma 73104, United States.
Ryan E LooperDepartment of Chemistry, University of Utah , 315 South 1400 East, Salt Lake City, Utah 84112, United States.
University of Utah · USOklahoma Medical Research Foundation · US

Funding

Synthetic and biological investigations of 2-aminoimidazole derived natural products.R01GM090082 · NIGMS · UNIVERSITY OF UTAH · PI LOOPER, RYAN EDWARD · 2010 to 2019
$2.6M
Identification of Novel Cancer Selective Compounds in 3D Tumor Organoid AssaysR01CA140296 · NCI · UNIVERSITY OF UTAH · PI SIGMAN, MATTHEW S · 2009 to 2013
$1.5M
NCI NIH HHS R01 CA140296NIGMS NIH HHS P41 GM08915NIGMS NIH HHS R01 GM090082
6 · The paper itself

Abstract

A short and scalable synthesis of naamidine A, a marine alkaloid with a selective ability to inhibit epidermal growth factor receptor (EGFR)-dependent cellular proliferation, has been achieved. A key achievement in this synthesis was the development of a regioselective hydroamination of a monoprotected propargylguanidine to deliver N(3)-protected cyclic ene-guanidines. This permits the extension of this methodology to prepare N(2)-acyl analogues in a fashion that obviates the troublesome acylation of the free 2-aminoimidazoles, which typically yields mixtures of N(2)- and N(2),N(2)-diacylated products.

Indexed as

AcylationAlkaloidsAminationAnimalsErbB ReceptorsGuanidinesImidazoles2-aminoimidazoleAlkaloidsErbB ReceptorsGuanidinesImidazolesnaamidine A

Identifiers

PMID26360634
PMCPMC5117189
OpenAlexW2415369201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.